PT3340975T - Formulação para o tratamento de acne - Google Patents

Formulação para o tratamento de acne

Info

Publication number
PT3340975T
PT3340975T PT167570183T PT16757018T PT3340975T PT 3340975 T PT3340975 T PT 3340975T PT 167570183 T PT167570183 T PT 167570183T PT 16757018 T PT16757018 T PT 16757018T PT 3340975 T PT3340975 T PT 3340975T
Authority
PT
Portugal
Prior art keywords
acne
formulation
treatment
Prior art date
Application number
PT167570183T
Other languages
English (en)
Inventor
Christian Opsahl Ross
Gina Butuc Steluta
Original Assignee
Nouryon Chemicals Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nouryon Chemicals Int Bv filed Critical Nouryon Chemicals Int Bv
Publication of PT3340975T publication Critical patent/PT3340975T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/327Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT167570183T 2015-08-28 2016-08-25 Formulação para o tratamento de acne PT3340975T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562211060P 2015-08-28 2015-08-28
EP15188210 2015-10-02

Publications (1)

Publication Number Publication Date
PT3340975T true PT3340975T (pt) 2019-11-04

Family

ID=56800291

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167570183T PT3340975T (pt) 2015-08-28 2016-08-25 Formulação para o tratamento de acne

Country Status (8)

Country Link
US (2) US10278945B2 (pt)
EP (1) EP3340975B1 (pt)
JP (1) JP6505945B2 (pt)
CN (1) CN107847479B (pt)
CA (1) CA2996095C (pt)
ES (1) ES2750873T3 (pt)
PT (1) PT3340975T (pt)
WO (1) WO2017036897A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210145760A (ko) * 2019-03-28 2021-12-02 호케트프레르 여드름, 비듬 및 악취의 미용적 영향을 없애기 위한 다이언하이드로헥시톨의 용도
DE102019109828A1 (de) * 2019-04-12 2020-10-15 Biodermic Health & Beauty GmbH & Co KG Zusammensetzung zur topischen Anwendung auf der Haut

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2913220A1 (de) * 1979-04-03 1980-10-23 Bayer Ag Kalthaertendes material
FR2604435B1 (fr) * 1986-09-30 1988-12-02 Oreal Peroxydes aromatiques insatures et leur utilisation en therapeutique et cosmetique
DD298591A5 (de) * 1989-11-22 1992-03-05 Biologische Zentralanstalt Berlin,De Fungizide mittel
KR20010110769A (ko) * 2000-02-17 2001-12-13 롤페스 요하네스 게라투스 알베르투스 반도체 디바이스 및 그 제조 방법
CA2785629A1 (en) * 2010-03-25 2011-09-29 Sol-Gel Technologies Ltd. Compositions for topical administration
PL3071651T3 (pl) * 2013-11-21 2018-06-29 Dsm Ip Assets B.V. Termoutwardzalne proszkowe kompozycje powlekające zawierające metylopodstawiony nadtlenek benzoilu

Also Published As

Publication number Publication date
JP2018525409A (ja) 2018-09-06
CN107847479A (zh) 2018-03-27
US20190321329A1 (en) 2019-10-24
BR112018003385A2 (pt) 2018-09-25
CN107847479B (zh) 2020-11-20
US20190022050A1 (en) 2019-01-24
ES2750873T3 (es) 2020-03-27
US10278945B2 (en) 2019-05-07
JP6505945B2 (ja) 2019-04-24
CA2996095C (en) 2023-08-15
CA2996095A1 (en) 2017-03-09
EP3340975B1 (en) 2019-07-24
EP3340975A1 (en) 2018-07-04
WO2017036897A1 (en) 2017-03-09

Similar Documents

Publication Publication Date Title
IL279627A (en) A method for treating depression
IL250960B (en) Combined treatment of sinecriviroc for the treatment of leprosy
IL247515A0 (en) Snekribirock for the treatment of leprosy
PL3524255T3 (pl) Kompozycja do leczenia trądziku
LT3109223T (lt) Junginys, skirtas karbamido turinčių trąšų apdorojimui
SI3122358T1 (sl) Kombinacije FGFR- in CMET-inhibitorjev za zdravljenje raka
IL259996A (en) Combinations for cancer treatment
GB201608885D0 (en) Treatment
IL249502A0 (en) Novel therapeutic uses of benzylideneguanidine derivatives for the treatment of protein-associated diseases
IL253617A0 (en) Snekribirock for the treatment of leprosy
EP3148556A4 (en) Skin treatment formulations
PL3184492T3 (pl) Preparat antyseptyczny
EP3226886A4 (en) Use of fibulin-5 for the treatment of keloid scars
EP3145525A4 (en) Use of microperoxidases for the treatment of carboxyhemoglobinemia
PT3340975T (pt) Formulação para o tratamento de acne
EP3323368A4 (en) TREATMENT TOOL
EP3200795A4 (en) Use of agents for treating fat-related disorders
IL255167A0 (en) Compounds for the treatment of cancer
ZA201704589B (en) Compounds for the treatment of cancer
PL3164110T3 (pl) Kompozycje farmaceutyczne do leczenia łuszczycy
PT3524255T (pt) Composição para o tratamento do acne
GB201617107D0 (en) Treatment
GB201612260D0 (en) Treatment
GB201612193D0 (en) Treatment
GB201609683D0 (en) Treatment